Dacron Pledget Suture Buttress
by Ethicon Inc.
510(k) K812254
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK812254 | Date31 Aug 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- DXZ
- FDA applicant
- ETHICON, Inc.
- Device class
- Class II
- Regulation
- 21 CFR Part 870.3470
- Advisory committee
- Cardiovascular
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
The Dacron Pledget Suture Buttress is a fabric-based intracardiac patch or pledget designed to reinforce and stabilize sutures during cardiovascular procedures. Constructed from materials such as polypropylene, polyethylene terephthalate (Dacron), or polytetrafluoroethylene (PTFE), it is intended for use in repairing septal defects, patch grafting, and tissue reinforcement within the heart.
This device is supplied in sterile, single-use configurations and is classified as a Class II medical device under FDA regulations. It is used in operating room settings for cardiovascular surgeries, with specific dimensions (e.g., 7mm × 7mm × 1.5mm or 9.5mm × 4.8mm × 1.5mm) tailored to procedural requirements. Authorized under FDA 510(k) clearance (K812254), it adheres to regulatory standards for intracardiac applications and is not intended for MRI use.
Other devices from Ethicon Inc.
Questions
AI-generated answers, 20 Sep 2026
What materials are the Dacron Pledget Suture Buttress made from, and how does this affect its use in cardiovascular procedures?
The Dacron Pledget Suture Buttress is constructed from materials like polypropylene, polyethylene terephthalate (Dacron), or polytetrafluoroethylene (PTFE). These materials provide structural reinforcement and stability to sutures during cardiovascular surgeries, such as repairing septal defects or patch grafting. The choice of materials ensures durability and compatibility with intracardiac tissues, reducing the risk of suture failure or displacement.
Are these pledgets reusable, or are they intended for single-use only? How should they be stored?
The Dacron Pledget Suture Buttress is supplied in sterile, single-use configurations, meaning each package is intended for one surgical procedure only. To maintain sterility, they should be stored in their original packaging, protected from moisture, extreme temperatures, and direct sunlight. Proper storage ensures the device remains uncontaminated and ready for use in the operating room.
What sizes are available for the Dacron Pledget Suture Buttress, and how do I determine the right size for a procedure?
The device comes in specific dimensions tailored to procedural needs, such as 7mm × 7mm × 1.5mm or 9.5mm × 4.8mm × 1.5mm. The correct size depends on the anatomical requirements of the patient and the surgical technique being used. Consulting preoperative imaging or working closely with the surgical team to assess defect size or graft requirements will help select the appropriate pledget dimensions.
Can the Dacron Pledget Suture Buttress be used with MRI imaging, or are there any restrictions?
The device is explicitly not intended for MRI use, as stated in the manufacturer’s documentation. This restriction is due to the potential risks associated with magnetic fields interacting with the materials used in the pledget, which could cause heating or displacement. Always verify imaging compatibility with the surgical team before or after use.
What regulatory pathway does the Dacron Pledget Suture Buttress follow, and what does this mean for clinicians?
The device was cleared through the FDA’s 510(k) pathway under the classification of a Class II medical device, with a decision described as Substantially Equivalent to a predicate device. This means it has undergone rigorous review by the FDA’s Cardiovascular (CV) Advisory Committee to ensure safety and effectiveness for intracardiac reinforcement procedures. Clinicians can trust that it meets established regulatory standards for use in cardiovascular surgeries.